Sysnav provides SV95C, the first regulatory-qualified real-world digital endpoint.

News and events

The latest news at Sysnav Healthcare

News

26 Feb 2024

SV95C Poster

At the 21st International Conference on Duchenne and Becker Muscular Dystrophy

Events

6 Feb 2024

Sysnav Healthcare at the 2024 MDA

Sysnav Healthcare is thrilled to announce its participation in the 2024 MDA Clinical & Scientific Conference in Orlando from 3rd March to 6th March 2024.

News

19 Dec 2023

SV95C Endpoint by Syde Highlighted by HealthXL

Sysnav Healthcare is proud to announce that the Syde-derived digital endpoint SV95C has been acknowledged in the report “Unlocking the Value of Digital Measures in Drug Development” by HealthXL in partnership with Biofourmis.

Events

29 Nov 2023

Sysnav Healthcare at Digital Biomarkers Event

Sysnav Healthcare is thrilled to be a part of “The Power of Digital Biomarkers” summit hosted by Sanofi on 30th November.

Events

28 Nov 2023

Sysnav Healthcare at Biotech’s ALS conference

Sysnav Healthcare is thrilled to be part of the upcoming conference hosted by France Biotech – “David Sagnier | SLA & maladies du motoneurone : quelles pistes pour demain? #2” on 29th November.

Events

6 Nov 2023

Sysnav Healthcare Sponsors FAST Summit 2023

Sysnav Healthcare is thrilled to announce its sponsorship of the 16th Annual FAST Global Science Summit from 9th-10th November 2023.

Events

3 Nov 2023

2023 Basel Biometric Society Meeting

Sysnav Healthcare is thrilled to announce its participation in the 2023 Basel Biometric Society’s Annual Meeting. Damien Eggenspieler, Director of the Healthcare Program, will be our representative at this event.

Events

9 Oct 2023

Sysnav Healthcare at ECTRIMS-ACTRIMS 2023

Sysnav Healthcare is thrilled to be participating in the 9th Joint ECTRIMS-ACTRIMS Meeting.

Events

8 Aug 2023

EMA Approves SV95C as Primary Endpoint in DMD

EMA opinion marks the first qualification of a digital outcome measure for use as a primary endpoint in pivotal drug trials